Sensus Healthcare Inc
sensushealthcare.comWhat Do They Do?
Sells low-energy X-ray treatment systems and related services for skin cancer and keloid treatment to dermatology practices and radiation oncologists.
10-K for FY2025, filed Mar 4, 2026Sensus Healthcare, Inc. (together, with its subsidiaries, Sensus Medical Devices Ltd. and Sensus Healthcare Services, LLC, unless the…View ↗
The SRT-100 is a photon x-ray low energy SRT system that provides patients an alternative to surgery for treating non-melanoma skin…View ↗
The Company’s focus is mainly on two primary markets, private dermatology practices and radiation oncologists in both private and hospital…View ↗
How Do They Make Money?
Customers buy treatment systems, with sales tied to shipment; maintenance contracts run over their term, while ad-hoc repairs and personnel work are billed as performed. Under Fair Deal, Sensus receives a contractual share of SRT reimbursements collected from payors.
10-K for FY2025, filed Mar 4, 2026Revenue is recognized upon transfer of control of promised goods or services to customers when the product is shipped or the service is…View ↗
The revenues from maintenance or repair service contracts are recognized over the service contract period on a straight-line basis. In the…View ↗
The revenues from personnel service contracts are recognized in the period that the work is performed, as the Company has elected the…View ↗
The Company offers the Fair Deal Agreement, a recurring revenue program that provides customers with a revenue-share turn-key solution to…View ↗
-
10-K for FY2025, filed Mar 4, 2026
FY2025 revenue by product or service ↗
$27.5M
-
10-K for FY2025, filed Mar 4, 2026
$27.5M ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Product
Sold outright
10-K for FY2025, filed Mar 4, 2026 |
72%
FY2022: 90%
|
Product, FY2025
$19.8M Sources
|
Sold outright |
|
Product Revenue
Recurring
|
6.3% |
Product Revenue, FY2025
$1.7M Sources
|
Recurring |
|
Service
Sold outright
|
9.3%
FY2022: 3.0%
|
Service, FY2025
$2.5M Sources
|
Sold outright |
|
Service Revenue
Recurring
10-K for FY2025, filed Mar 4, 2026 |
13%
FY2022: 7.1%
|
Service Revenue, FY2025
$3.5M Sources
|
Recurring |
Who Are Their Customers?
Sells directly in the U.S. through its sales force and internationally through dealers and distributors, serving private dermatology practices and radiation oncologists in private and hospital settings.
10-K for FY2025, filed Mar 4, 2026The Company’s focus is mainly on two primary markets, private dermatology practices and radiation oncologists in both private and hospital…View ↗
10-K for FY2025, filed Mar 4, 2026
One customer in the United States accounted for 52% and 73% of revenue for the years ended December 31, 2025 and 2024, respectively, and…View ↗
Do Revenues Turn Into Profits?
Not on paper. It lost $7.7M in FY2025, but brought in more cash than it spent: $332K of free cash flow.
10-K for FY2025, filed Mar 4, 2026
−$10.3MView ↗
10-K for FY2025, filed Mar 4, 2026
−$7.7MView ↗
10-K for FY2025, filed Mar 4, 2026
$332KView ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 14, 2026
−$8.7MView ↗
- ▲ +744% (Loss)
- vs −$1M in Q2 FY2025
10-Q for Q2 FY2026, filed Aug 14, 2026
Open tableView ↗
Flat. Revenue was $27.5M in FY2025, about the same as the $27M of FY2021.
Loading...
